Please login to the form below

Not currently logged in
Email:
Password:

Valeant completes AB Sanitas purchase

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m.

Announced in May 2011, the deal will see Valeant take full control of the Lithuania-based speciality pharmaceutical firm, gaining 390 generic products in nine Central and Eastern European countries.

Valeant has made several acquisitions in 2011, including the February purchase of privately held firm PharmaSwiss for €350m. This was followed in July by the acquisition of Sanofi's Dermik dermatology unit for $425m.

At the end of July 2011, Valeant was rumoured to be considering making a bid for Sweden-based Meda, and in August 2011, The Wall Street Journal reported Valeant was to purchase dermatological specialists Medicis.

22nd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
...
Londonvelophobia (fear of cycling in London) – debunked
...
How Helpful are Simple Health Messages?
...

Infographics